Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks

Clinical trial NCT03954743 · COMPLETED

Trial details

NCT number: NCT03954743
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Rotavirus

Start date: 2019-07-19
Primary completion: 2020-11-30
Enrollment: 1351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.